Thapanee Somboon (Cleveland Clinic, OH) talks us through the key findings of her two presentations, which focused on the prevalence of high risk obstructive sleep apnea and insomnia in neurological populations (abstract available here) and the performance of sleep apnea screening tools in former professional athletes (abstract available here).
Questions
1. How prevalent are obstructive sleep apnea and insomnia in neurological populations? (0:11)
2. How effective are the STOP score and insomnia severity index in assessing obstructive sleep apnea and insomnia in neurological populations? (0:58)
3. What is the impact of high STOP score and insomnia severity index on neurological disease outcomes? (1:39)
4. What are the advantages and the limitations of home sleep apnea tests (HSAT) in assessing obstructive sleep apnea? (3:10)
5. What were the findings of your study comparing the STOP-BANG questionnaire and HSAT in professional athletes? (3:55)
To view full article click here.
.
Speaker disclosure: Thapanee Somboon has nothing to disclose in relation to this video interview.
Filmed at the American Academy of Neurology (AAN) Annual Meeting 2018, Los Angeles, CA, US, April 2018.
